Literature DB >> 25569159

Genome-wide identification of CBX2 targets: insights in the human sex development network.

Wassim Eid1, Lennart Opitz, Anna Biason-Lauber.   

Abstract

Chromobox homolog 2 (CBX2) is a chromatin modifier that plays an important role in sexual development and its disorders (disorders of sex development [DSD]), yet the exact rank and function of human CBX2 in this pathway remains unclear. Here, we performed large-scale mapping and analysis of in vivo target loci of the protein CBX2 in Sertoli-like NT-2D1 cells, using the DNA adenine methyltransferase identification technique. We identified close to 1600 direct targets for CBX2. Intriguingly, validation of selected candidate genes using qRT-PCR in cells overexpressing CBX2 or in which CBX2 has been knocked down indicated that several CBX2-responsive genes encode proteins that are involved in DSD. We further validated these effects on the candidate genes using a mutated CBX2 causing DSD in human patient. Overall, our findings suggest that CBX2 role in the sex development cascade is to stimulate the male pathway and concurrently inhibit the female pathway. These data provide fundamental insights into potential etiology of DSD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25569159      PMCID: PMC5414760          DOI: 10.1210/me.2014-1339

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  45 in total

1.  The potential role of microRNAs in regulating gonadal sex differentiation in the chicken embryo.

Authors:  Andrew D Cutting; Stephanie C Bannister; Tim J Doran; Andrew H Sinclair; Mark V L Tizard; Craig A Smith
Journal:  Chromosome Res       Date:  2012-01       Impact factor: 5.239

Review 2.  Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins.

Authors:  Leonie Ringrose; Renato Paro
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

Review 3.  Polycomb silencers control cell fate, development and cancer.

Authors:  Anke Sparmann; Maarten van Lohuizen
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

4.  Cbx2, a polycomb group gene, is required for Sry gene expression in mice.

Authors:  Yuko Katoh-Fukui; Kanako Miyabayashi; Tomoko Komatsu; Akiko Owaki; Takashi Baba; Yuichi Shima; Tomohide Kidokoro; Yoshiakira Kanai; Andreas Schedl; Dagmar Wilhelm; Peter Koopman; Yasushi Okuno; Ken-ichirou Morohashi
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

5.  Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans.

Authors:  B K Jordan; M Mohammed; S T Ching; E Délot; X N Chen; P Dewing; A Swain; P N Rao; B R Elejalde; E Vilain
Journal:  Am J Hum Genet       Date:  2001-03-29       Impact factor: 11.025

6.  A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46,XX woman.

Authors:  Anna Biason-Lauber; Daniel Konrad; Francesca Navratil; Eugen J Schoenle
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

7.  Mice deficient for testis-brain RNA-binding protein exhibit a coordinate loss of TRAX, reduced fertility, altered gene expression in the brain, and behavioral changes.

Authors:  Vargheese Chennathukuzhi; Joel M Stein; Ted Abel; Stacy Donlon; Shicheng Yang; Juli P Miller; David M Allman; Rebecca A Simmons; Norman B Hecht
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

8.  Male pseudohermaphroditism in sibs with the alpha-thalassemia/mental retardation (ATR-X) syndrome.

Authors:  W Reardon; R J Gibbons; R M Winter; M Baraitser
Journal:  Am J Med Genet       Date:  1995-01-30

9.  Hypospadias and genes related to genital tubercle and early urethral development.

Authors:  Suzan L Carmichael; Chen Ma; Shweta Choudhry; Edward J Lammer; John S Witte; Gary M Shaw
Journal:  J Urol       Date:  2013-05-30       Impact factor: 7.450

10.  Clinical whole-exome sequencing: are we there yet?

Authors:  Paldeep Singh Atwal; Marie-Louise Brennan; Rachel Cox; Michael Niaki; Julia Platt; Margaret Homeyer; Andrea Kwan; Sylvie Parkin; Susan Schelley; Leah Slattery; Yael Wilnai; Jonathan Adam Bernstein; Gregory M Enns; Louanne Hudgins
Journal:  Genet Med       Date:  2014-02-13       Impact factor: 8.822

View more
  7 in total

Review 1.  Vertebrate sex determination: evolutionary plasticity of a fundamental switch.

Authors:  Blanche Capel
Journal:  Nat Rev Genet       Date:  2017-08-14       Impact factor: 53.242

2.  A Human Gonadal Cell Model From Induced Pluripotent Stem Cells.

Authors:  Daniel Rodríguez Gutiérrez; Wassim Eid; Anna Biason-Lauber
Journal:  Front Genet       Date:  2018-10-24       Impact factor: 4.599

3.  Two transcriptionally distinct pathways drive female development in a reptile with both genetic and temperature dependent sex determination.

Authors:  Sarah L Whiteley; Clare E Holleley; Susan Wagner; James Blackburn; Ira W Deveson; Jennifer A Marshall Graves; Arthur Georges
Journal:  PLoS Genet       Date:  2021-04-15       Impact factor: 5.917

4.  Assembling the jigsaw puzzle: CBX2 isoform 2 and its targets in disorders/differences of sex development.

Authors:  Patrick Sproll; Wassim Eid; Camila R Gomes; Berenice B Mendonca; Nathalia L Gomes; Elaine M-F Costa; Anna Biason-Lauber
Journal:  Mol Genet Genomic Med       Date:  2018-07-11       Impact factor: 2.183

5.  CBX2-dependent transcriptional landscape: implications for human sex development and its defects.

Authors:  Patrick Sproll; Wassim Eid; Anna Biason-Lauber
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

6.  The transcriptional regulator CBX2 and ovarian function: A whole genome and whole transcriptome approach.

Authors:  Leila Bouazzi; Patrick Sproll; Wassim Eid; Anna Biason-Lauber
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

7.  Effects of Wnt/β-Catenin Signal Pathway Regulated by miR-342-5p Targeting CBX2 on Proliferation, Metastasis and Invasion of Ovarian Cancer Cells.

Authors:  Yan Dou; Fengxia Chen; Yawan Lu; Huanhuan Qiu; Hongmei Zhang
Journal:  Cancer Manag Res       Date:  2020-05-21       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.